Aton (EPA:ALTAO)

France flag France · Delayed Price · Currency is EUR
0.0062
+0.0002 (3.33%)
At close: Jan 30, 2026
-37.37%
Market Cap5.13M -37.7%
Revenue (ttm)656.93K +102.0%
Net Income-115.68K
EPS-0.00
Shares Out828.12M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume315,019
Average Volume618,514
Open0.0062
Previous Close0.0060
Day's Range0.0060 - 0.0062
52-Week Range0.0050 - 0.0108
Beta0.28
RSI47.99
Earnings DateApr 30, 2026

About Aton

Aton operates as a bioscience company in France. It engages in drug development, preclinical and clinical services, production of monoclonal antibodies, laboratory equipment production, and designing and manufacturing of medical devices, as well as provision of human tissues. The company also offers medical devices for surgeons, powered by Stemcis. The company was founded in 1998 and is headquartered in Strasbourg, France. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 9
Stock Exchange Euronext Paris
Ticker Symbol ALTAO
Full Company Profile

Financial Performance

In 2024, Aton's revenue was 614,000, an increase of 0.33% compared to the previous year's 612,000. Losses were -1.10 million, -86.01% less than in 2023.

Financial Statements